Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels. (3rd March 2020)

Record Type:: Journal Article
Title:: Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels. (3rd March 2020)
Main Title:: Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
Authors:: Sibille, A.
Henket, M.
Corhay, J. L.
Louis, R.
Duysinx, B.
Abstract:
Is Part Of:: Acta oncologica. Volume 59:Number 3(2020)
Journal:: Acta oncologica
Issue:: Volume 59:Number 3(2020)
Issue Display:: Volume 59, Issue 3 (2020)
Year:: 2020
Volume:: 59
Issue:: 3
Issue Sort Value:: 2020-0059-0003-0000
Page Start:: 257
Page End:: 259
Publication Date:: 2020-03-03
Subjects:: Oncology -- Periodicals
Cancer -- Treatment -- Periodicals
616.992
Journal URLs:: http://informahealthcare.com/loi/onc ↗
http://informahealthcare.com ↗
DOI:: 10.1080/0284186X.2019.1695063 ↗
Languages:: English
ISSNs:: 0284-186X
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 0641.705000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12893.xml